Abstract Pediatric uveitis accounts for 5–10% of all uveitis. Uveitis in children differs from
adult uveitis in that it is commonly asymptomatic and can become chronic and cause …

A generation ago, children with arthritis faced a lifetime of pain and disability. Today, there
are a multitude of treatment options, including a variety of biologics targeting key cytokines …

Objective To develop recommendations for the screening, monitoring, and treatment of
uveitis in children with juvenile idiopathic arthritis (JIA). Methods Pediatric rheumatologists …

Juvenile idiopathic arthritis (JIA) is the commonest rheumatic disease in children and JIA-
associated uveitis its most frequent extra-articular manifestation. The uveitis is potentially …

Background Arthritis involving the temporomandibular joint (TMJ) complicates 40-96% of
cases of juvenile idiopathic arthritis (JIA), potentially leading to devastating changes to form …

Uveitis associated with juvenile idiopathic arthritis (JIA) typically involves the anterior
chamber segment, follows an indolent chronic course, and presents a high rate of uveitic …

Since the first reported use in 2001 of an anti–tumor necrosis factor-alpha (TNF-α) agent,
infliximab, for the treatment of uveitis, several new anti–TNF-α agents have emerged for the …

Background Uveitis in juvenile idiopathic arthritis (JIAU) is frequently associated with the
development of complications and visual loss. Topical corticosteroids are the first line …

Systemic juvenile idiopathic arthritis (sJIA) is generally seen as the most severe category of
JIA. These categories are distinct in their pathobiology, disease course and specific …

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of
childhood. The outcome in patients with JIA has markedly improved with the advent of …